Work with thought leaders and academic experts in Pharmacy

Companies can greatly benefit from working with experts in the field of Pharmacy. These researchers bring a wealth of knowledge and experience that can enhance various aspects of a company's operations. Here are some ways companies can collaborate with academic researchers in Pharmacy: 1. Research and Development: Academic researchers can contribute to the development of new drugs, therapies, and treatment methods. Their expertise can help companies in the pharmaceutical industry stay at the forefront of innovation. 2. Clinical Trials: Researchers can assist in designing and conducting clinical trials for new drugs. Their knowledge of regulatory requirements and ethical considerations ensures the trials are conducted effectively and safely. 3. Drug Safety and Efficacy: Academic researchers can evaluate the safety and efficacy of existing drugs. Their findings can help companies improve their products and ensure patient safety. 4. Pharmacovigilance: Researchers can monitor and analyze adverse drug reactions and provide insights into drug safety. This helps companies identify potential risks and take appropriate measures. 5. Education and Training: Academic researchers can provide training and education to company employees, keeping them updated on the latest advancements in Pharmacy. 6. Collaboration on Grants and Funding: Researchers can collaborate with companies on grant applications and funding opportunities, leveraging their expertise to secure funding for research projects. 7. Regulatory Compliance: Academic researchers can assist companies in navigating complex regulatory frameworks and ensuring compliance with industry standards. 8. Market Research: Researchers can conduct market research to identify trends, consumer preferences, and competitive landscapes. This information helps companies make informed decisions and develop effective marketing strategies. By collaborating with academic researchers in Pharmacy, companies can tap into a vast pool of knowledge and expertise, leading to improved products, enhanced research capabilities, and a competitive edge in the industry.

Researchers on NotedSource with backgrounds in Pharmacy include Dr Kalliopi Dodou, Ph.D., Luke Connelly, Balamurugan Tangiisuran, Jenya Antonova, Jonathan D. Agnew, PhD, MBA, Sheraz Ch, Jorge Vasquez-Kool, Nitin Pandey, Vicky Mody, Parisa Lotfi, and Michael Avaltroni.

Dr Kalliopi Dodou, Ph.D.

Nunthorpe
21 Years Experience
University of Teesside
Education

Ph.D, Medicinal Chemistry / July, 2004

Sunderland

University of Sunderland

BSc, Pharmacy / July, 1999

Sunderland
Experience

Teesside University

Head of Pharmaceutics / January, 2024 — Present

University of Sunderland

Lecturer/Senior Lecturer/Associate Professor in Pharmaceutical and Cosmetic Sciences / October, 2004 — January, 2024

Most Relevant Research Expertise
pharmacy
Other Research Expertise (9)
Drug delivery
transdermal dosage forms
pharmaceutics
cosmetic product formulation
cosmetic product quality control
And 4 more
About
Dr Kalliopi Dodou is a highly experienced and knowledgeable academic with a strong background in the field of pharmaceutical and cosmetic sciences. She obtained her Ph.D. in Medicinal Chemistry in 2004 and has since then dedicated her career to teaching and research. Dr Dodou began her academic journey with a Bachelor of Science degree in Pharmacy from the University of Sunderland in 1999. She then went on to complete her Ph.D. where she conducted research on the development of novel agents for the treatment of skin psoriasis. After completing her Ph.D., Dr Dodou then moved on to become a Lecturer, Senior Lecturer, and eventually an Associate Professor in Pharmaceutical and Cosmetic Sciences at the University of Sunderland. In these roles, she taught a wide range of courses related to pharmaceutical sciences, and she designed two Cosmetic Science courses. In 2024 she moved to Teesside University as a Head of Pharmaceutics. In this role, she is responsible for managing the pharmaceutics department and overseeing the development and delivery of courses related to drug formulation and delivery. Throughout her career, Dr Dodou has led various research projects, she has published numerous papers in reputable scientific journals, and she has directed over 10 PhD students. She has also acted as consultant to the pharmaceutical and cosmetic industry on R&D and patent litigation cases. She is the creator of a patent on transdermal drug delivery. Dr Dodou is highly respected in the academic and research communities for her expertise and contributions to the field of pharmaceutical and cosmetic sciences.

See Full Profile

Luke Connelly

25 Years Experience
Professor of Health Economics, The University of Queensland, CBEH
Education

University of Queensland

PhD, School of Economics / June, 1999

Brisbane, Queensland, Australia

University of Queensland

Master of Economic Studies, School of Economics / December, 1993

Brisbane, Queensland, Australia

University of Queensland

Bachelor of Arts (Economics), School of Economics / November, 1991

Brisbane, Queensland, Australia
Experience

The University of Bologna

Professor

The University of Queensland

Professor of Health Economics / May, 2015 — Present

Professor of Health Economics and Associate Director / January, 2008 — August, 2015

Associate Professor and Associate Director / May, 2003 — December, 2007

Queensland University of Technology

Senior Lecturer in Economics / May, 2000 — April, 2003

Lecturer / January, 1998 — April, 2000

Most Relevant Research Expertise
Pharmacy
Other Research Expertise (42)
Health economics
insurance
Public Health, Environmental and Occupational Health
Safety, Risk, Reliability and Quality
Human Factors and Ergonomics
And 37 more
About
Luke Connelly is Professor of Health Economics at the Centre for the Business and Economics of Health. He also holds a Professorial appointment (part-time) at The University of Bologna, to which he was appointed in 2017 via the Italian “Direct Call” ([link](https://www.unibo.it/sitoweb/luke.connelly/en)) process. In 2019 he was appointed as Honorary Professor at The University of Sydney. His main interests are in health economics and insurance economics and the effects of institutions (including legal constructs) on incentives and behaviour. He has also worked in other fields of applied microeconomics, including education economics and transport economics. His publications include papers in *Review of Income and Wealth*, *Health Economics*, *Journal of Health Economics*, *Journal of Risk and Insurance*, *Geneva Papers on Risk and Insurance*, *Accident Analysis and Prevention*, *Journal of Law and Medicine*, *Journal of Clinical Epidemiology*, *European Journal of Health Economics*, *International Journal of Health Economics and Finance*, *Social Science and Medicine*, *Economic Papers*, *Economic Analysis and Policy*, *Journal of Transport Economics and Policy*, *Labour Economics*, *Economics and Human Biology* as well as in a range of clinical journals, including *Lancet*. Luke has served on a number of public committees including the Medical Services Advisory Committee (MSAC), which advises the Australian Minister for Health on the safety, efficacy, effectiveness, and cost-effectiveness of new and extant listings on Australia's Medicare Benefits Schedule. He has extensive service on other public committees and taskforces as well as extensive teaching and consulting engagements with industry. Over his career he has been a chief investigator on research grants and contracts totalling more than $67m. He is a member of the Editorial Boards of European Journal of Health Economics and the International Journal on Environmental Research and Public Health. He is a member of the International Health Economics Association's Arrow Awards Committee, which awards an annual prize in honour of Nobel Laureate Kenneth Arrow for the best paper in the field. He is currently Guest Editor (with Christophe Courbage) on a Special Issue of the Geneva Papers on Risk and Insurance on Insurance and Emerging Health Risks. His current research interests include health service innovations to improve the health of people with chronic kidney disease(CKD). Ongoing interests include the economics of disability and insurance, compensable injury compensation schemes, and the determinants of health. Luke enjoys and has considerable experience teaching economics and health economics at both the graduate and undergraduate levels. In 2014 he was awarded the School of Economics Distinguished Teaching Award for his teaching on UQ's Master of Health Economics Program. In July 2016 and July 2019 he also taught summer schools in Health Economics and the Economics of Insurance at The University of Lucerne, Switzerland. Over the past 10 years he has been a chief investigator on grants totalling more than $70m.
Most Relevant Publications (1+)

105 total publications

Impact of pharmacist and physician collaborations in primary care on reducing readmission to hospital: A systematic review and meta-analysis

Research in Social and Administrative Pharmacy / Jun 01, 2022

Foot, H., Scott, I., Sturman, N., Whitty, J. A., Rixon, K., Connelly, L., Williams, I., & Freeman, C. (2022). Impact of pharmacist and physician collaborations in primary care on reducing readmission to hospital: A systematic review and meta-analysis. Research in Social and Administrative Pharmacy, 18(6), 2922–2943. https://doi.org/10.1016/j.sapharm.2021.07.015

See Full Profile

Balamurugan Tangiisuran

Boston, Massachusetts, United States of America
14 Years Experience
Associate Professor in Clinical Pharmacy at Universiti Sains Malaysia
Education

Ph.D, Medication safety in Geriatrics / March, 2010

Sussex
Most Relevant Research Expertise
Pharmacy
Other Research Expertise (51)
Geriatrics
Internal Medicine
Psychiatry and Mental health
Clinical Psychology
Pharmacology
And 46 more
About
Dr. Bala brings a wealth of knowledge and expertise to his role as an Associate Professor in Clinical Pharmacy at the School of Pharmaceutical Sciences, USM. He has a proven track record of success in his field, having held key leadership positions such as Director at the Malaysian National Poison Centre and Program Chairman (Clinical Pharmacy) at the School of Pharmaceutical Sciences, USM. He holds a Bachelor of Pharmacy from USM and a PhD from Brighton and Sussex Medical School, UK. Additionally, he has been appointed as Visiting Senior Lecturer at King's College London and as a Fellow of the WHO Collaborating Centre for Drug Information at the National Poison Centre. <br> Bala's research focuses on the areas of clinical pharmacy practice and medication safety, as well as geriatric pharmacy. He has published more than 50 peer-reviewed journal articles/abstracts and has been invited as a guest speaker at numerous international and domestic scientific events. He is an experienced internal and external examiner for over 40 PhD and Master thesis and has actively reviewed manuscripts for international academic journals. Bala's teaching activities encompass both undergraduate and postgraduate-level instruction, and he has supervised the research of numerous postgraduate students. He is committed to curriculum development and has implemented innovative and interactive teaching methods to improve student learning outcomes. He has successfully graduated 24 students, including 4 PhDs, 4 MSc, and 16 Master in Clinical Pharmacy. He is dedicated to producing sustainable pharmacy education and closing the knowledge transfer gap for students. If you're interested in Clinical Pharmacy, Geriatric pharmacy, Medication Safety, Research and Education, feel free to connect and exchange ideas.
Most Relevant Publications (4+)

78 total publications

Evaluation of potentially inappropriate medications among older residents of Malaysian nursing homes

International Journal of Clinical Pharmacy / May 24, 2012

Chen, L. L., Tangiisuran, B., Shafie, A. A., & Hassali, M. A. A. (2012). Evaluation of potentially inappropriate medications among older residents of Malaysian nursing homes. International Journal of Clinical Pharmacy, 34(4), 596–603. https://doi.org/10.1007/s11096-012-9651-1

Knowledge and practices of community pharmacists towards non-prescription dispensing of antibiotics in Northern Nigeria

International Journal of Clinical Pharmacy / Apr 01, 2020

Abubakar, U., & Tangiisuran, B. (2020). Knowledge and practices of community pharmacists towards non-prescription dispensing of antibiotics in Northern Nigeria. International Journal of Clinical Pharmacy, 42(2), 756–764. https://doi.org/10.1007/s11096-020-01019-y

Physicians’ perceived barriers and enablers for deprescribing among older patients at public primary care clinics: a qualitative study

International Journal of Clinical Pharmacy / Oct 12, 2021

Tangiisuran, B., Rajendran, V., Sha’aban, A., Daud, N. A. A., & Nawi, S. N. M. (2021). Physicians’ perceived barriers and enablers for deprescribing among older patients at public primary care clinics: a qualitative study. International Journal of Clinical Pharmacy, 44(1), 201–213. https://doi.org/10.1007/s11096-021-01336-w

Impact of adherence to key performance indicators on mortality among patients managed for ischemic stroke

Pharmacy Practice / Mar 31, 2020

Mohammed, M., Zainal, H., Tangiisuran, B., Harun, S. N., Ghadzi, S. M., Looi, I., Sidek, N. N., Yee, K. L., & Aziz, Z. A. (2020). Impact of adherence to key performance indicators on mortality among patients managed for ischemic stroke. Pharmacy Practice, 18(1), 1760. https://doi.org/10.18549/pharmpract.2020.1.1760

See Full Profile

Jenya Antonova

16 Years Experience
Independent Health Economist with deep expertise in PRO and COA, fusing a passion for winning strategies with a track record of award-winning research excellence
Education

University of Wisconsin–Madison

Ph.D., Health system engineering / June, 2008

Madison, Wisconsin, United States of America

University of Wisconsin–Madison

M.S., Health Services Research / June, 2006

Madison, Wisconsin, United States of America

University of Wisconsin–Madison

M.S., Industrial and system engineering / June, 2005

Madison, Wisconsin, United States of America
Experience

Compass Strategy and Research, Inc.

Principal Scientist / February, 2022 — Present

Was hired to maximize treatment value through patient-centered outcomes • Support executive team to enhance product value proposition through robust Value & Access strategy • Champion excellence in HEOR and PRO/COA strategy implementation through effective in-house project management and strategic oversight • Maximize the value propositions of medical products through the development of HEOR and PRO/COA strategy focused on multiple stakeholders (patients, caregivers, regulators, HTA and payer agencies, and policymakers) • Persuasively communicated the unique value of products to multiple stakeholders, securing their support and partnership • Enable excellence and compliance in the planning, execution, and publication of HEOR and PRO/COA research by optimizing scientific planning, oversight, and publication approval processes

Aqtual, Inc.

Head of Value & Access / January, 2023 — December, 2023

Was hired to build V&A capacity and shape the product value proposition • Addressed and resolved pivotal issues to refine business strategies and optimize decision-making in development programs • Crafted and articulated a compelling product value story, tailored to optimize value from the payer perspective • Formulated a robust Value & Access (V&A) strategy, concentrating on current and future indications to enhance market positioning • Established strategic relationships with key payer decision-makers, fostering avenues for impactful collaborations • Facilitated a standout market debut for a company emerging from stealth mode through strategic planning and execution of key publications • Established and maintained company-level standards of excellence and compliance in HEOR and PRO/COA research planning, execution, and publication, through streamlined scientific planning, meticulous oversight, and robust publication approval processes

Gilead Sciences, Inc.

Director, PRO and COA Center of Excellence / March, 2020 — February, 2022

Was hired to ensure excellence in COA strategy, execution, analyses, and publications • Enabled successful PRO discussions with regulatory agencies (FDA, EMA) by contributing to briefing documents and participating in meetings with the FDA • Drove excellence in patient-focused drug development by developing training on the value of PRO/COA for multiple stakeholders and best practices in PRO/COA strategy and research • Ensured success of critical (high-priority and high-visibility) projects by advising therapeutic-area HEOR colleagues on PRO strategy during launches, protocol design, COA analyses, and regulatory communications • Enabled excellence and compliance in the planning, execution, and publication of PRO/COA research by optimizing scientific planning, oversight, and publication approval processes • Maximized the value of Gilead products by optimizing PRO/COA for HTA and payer decisions

Director, Health Economics and Outcomes Research / September, 2017 — February, 2020

Was hired to create a comprehensive research agenda to demonstrate the value of a multi-indication product via real-world evidence and clinical outcome assessment • Led, developed, and executed HEOR strategy supporting a product launch • Communicated the value Gilead products by leading 25+ publications • Gilead Sciences (continued) • Enabled successful publications of PRO and COA in clinical trial result in oncology, inflammation, liver disease • Strengthened clinical programs by informing clinical trial design, statistical analysis plans, and best practices in PRO and COA methodology • Elevated Gilead recognition in the clinical and scientific communities by cultivating and managing relationships with clinical experts and key opinion leaders (KOLs)

Most Relevant Research Expertise
Pharmacy
Other Research Expertise (19)
Pharmaceutical Science
Health Policy
Dermatology
Immunology and Allergy
Immunology
And 14 more
About
As an independent health economist, I am opening my schedule to new projects and partnerships. Contact me if you need expert support with patient-reported outcomes (PROs), clinical outcome assessment (COA), or health economics and outcomes research (HEOR). #OpenToWork   My clients hire me for my strategic acumen, organizational agility, holistic vision, and scientific excellence in project execution. Here's a snapshot of areas where I've had the privilege to make an impact:   **HEOR Strategic Acumen:** Tailored value propositions, access strategies, and evidence generation plans that resonate with payers, regulators, policymakers, healthcare providers, and patients.   **PRO & COA Strategic and Tactical Support**: Maximized the value of products through robust and comprehensive PRO and COA strategy for regulatory, HTA, and publication purposes; supported regulatory communications; demonstrated excellence in the execution of PRO and COA dossiers, statistical analysis plans, clinical study reports, and publications.   **Literature Reviews**: Executed targeted (quick and clean) and systematic literature reviews that deliver insights that drive strategy.   **In-House Support and Collaborative Leadership**: Provided strategic in-house tactical support and adeptly steered cross-functional collaboration within matrix organizations, leading to unified progress and shared victories.
Most Relevant Publications (1+)

21 total publications

Patient Outcomes, Health Care Resource Use, and Costs Associated with High Versus Low HEDIS Asthma Medication Ratio

Journal of Managed Care &amp; Specialty Pharmacy / Nov 01, 2017

Luskin, A. T., Antonova, E. N., Broder, M. S., Chang, E., Raimundo, K., & Solari, P. G. (2017). Patient Outcomes, Health Care Resource Use, and Costs Associated with High Versus Low HEDIS Asthma Medication Ratio. Journal of Managed Care &amp; Specialty Pharmacy, 23(11), 1117–1124. https://doi.org/10.18553/jmcp.2017.23.11.1117

See Full Profile

Jonathan D. Agnew, PhD, MBA

10 Years Experience
Medical writer with PhD in health services research (UC Berkeley), MBA (London), and AB (Brown University)
Education

University of London

MBA, Royal Holloway / May, 2014

London

University of California, Berkeley

PhD, Health Policy / May, 2002

Berkeley

Brown University

AB (hons), Biology and Community Health / June, 1997

Providence
Experience

University of British Columbia

Adjunct Professor / December, 2018 — Present

Agnew & Associates Medical Writing

Principal / November, 2013 — Present

Most Relevant Research Expertise
Pharmacy
Other Research Expertise (2)
Health Policy
Pharmaceutical Science
About
Dr. Agnew is an adjunct professor at the University of British Columbia and a principal at Agnew & Associates Medical Writing. His research and work focuses on the development and evaluation of health policy initiatives and medical writing support for academic, pharmaceutical, and medical device industries.
Most Relevant Publications (1+)

5 total publications

Financial Risk Relationships and Adoption of Management Strategies in Physician Groups for Self-Administered Injectable Drugs

Journal of Managed Care Pharmacy / Nov 01, 2003

Agnew, J. D., Stebbins, M. R., Hickman, D. E., & Lipton, H. L. (2003). Financial Risk Relationships and Adoption of Management Strategies in Physician Groups for Self-Administered Injectable Drugs. Journal of Managed Care Pharmacy, 9(6), 523–533. https://doi.org/10.18553/jmcp.2003.9.6.523

See Full Profile

Sheraz Ch

8 Years Experience
1DANA Brain Health Institute, Iranian Neuroscience Society-Fars Chapter, Shiraz, Iran 2Senses Cultural Foundation, Sacramento, CA, USA
Education

University of Eastern Finland

Masters in Public Health (MPH) / December, 2014

Kuopio

Baqai Medical University

Doctor of Pharmacy (PharmD) / April, 2011

Karachi
Experience

University of Tasmania, Australia

PhD Research Scholar / March, 2020 — Present

Ministry of Health

Head of Scientific and Staff Development / July, 2019 — February, 2020

Researcher / November, 2015 — February, 2020

London School of Hygiene and Tropical Medicine

Co-investigator, CRASH-3 Study / May, 2016 — September, 2017

Most Relevant Research Expertise
Pharmacy
Other Research Expertise (15)
Neuroimaging
Machine learning
Brain disorder
Deep learning
Brain signal processing
And 10 more
Most Relevant Publications (2+)

15 total publications

Hospital pharmacists’ awareness and perspective toward the management of COVID-19 pandemic in the Kingdom of Saudi Arabia

Pharmacy Practice / Sep 23, 2022

Salem Al-Dossari, D., Abdulaziz Al-Zaagi, I., Bamogaddam, R. F., Hamoud Alnajrani, R., Rashid Alnajrani, N., Najib Alajami, H., Abdullah AlOtaibi, R., AlShammary, K. S., AlOtaibi, A. J., Yousaf, A., & Ali, S. (2022). Hospital pharmacists’ awareness and perspective toward the management of COVID-19 pandemic in the Kingdom of Saudi Arabia. Pharmacy Practice, 20(3), 01–07. https://doi.org/10.18549/pharmpract.2022.3.2709

Knowledge and Barriers Among Physicians Toward Adverse Drug Reaction Reporting at a Tertiary Care Hospital in Saudi Arabia

Hospital Pharmacy / Mar 04, 2020

Al-Abdulkarim, D. A., Aljadhey, H. S., Mahmoud, M. A., Poff, G. A., Hassali, M. A., & Ali, S. (2020). Knowledge and Barriers Among Physicians Toward Adverse Drug Reaction Reporting at a Tertiary Care Hospital in Saudi Arabia. Hospital Pharmacy, 56(4), 368–373. https://doi.org/10.1177/0018578720910385

See Full Profile

Jorge Vasquez-Kool

Raleigh, NC, North Carolina, United States of America
16 Years Experience
Senior researcher and educator with broad background in life sciences
Education

NC State University

Ph.D., Biotechnology, Protein Structure / May, 2002

Raleigh, North Carolina, United States of America

North Carolina State University

Master of Science, Plant Breeding, Quantitative Genetics

Raleigh, North Carolina, United States of America
Experience

Shaw University

Assistant Professor / 2022 — Present

Arrayxpress

Senior Scientist / May, 2012 — Present

Meredith College

Adjunct Professor / 2019 — 2021

Most Relevant Research Expertise
Pharmacy
Other Research Expertise (17)
Plant Science
Pharmacology
Drug Discovery
Complementary and alternative medicine
Organic Chemistry
And 12 more
Most Relevant Publications (1+)

9 total publications

A visual thinking strategy enhances an undergraduate human physiology course offered by a Peruvian Pharmacy and Biochemistry School

Pharmacy Education / Jun 28, 2022

Marín Tello, C., Guevara-Vásquez, A. M., Amaya-Lau, L., Rafael-Manosalva, Y., Villafana-Medina, H., & Vásquez-Kool, J. (2022). A visual thinking strategy enhances an undergraduate human physiology course offered by a Peruvian Pharmacy and Biochemistry School. Pharmacy Education, 22(1), 647–653. https://doi.org/10.46542/pe.2022.221.647653

See Full Profile

Nitin Pandey

9 Years Experience
Assistant Professor of Physiology and Neuroscience, University of Southern California
Education

IIT Kharagpur

PhD, Chemistry / July, 2014

Kharagpur

Banaras Hindu University

MS, Chemistry

Varanasi
Experience

University of Southern California

Postdoctoral research Associate / June, 2014 — May, 2019

Research Associate / June, 2019 — June, 2021

Assistant Professor of Research / July, 2021 — Present

Most Relevant Research Expertise
Pharmacy
Other Research Expertise (26)
Protein misfolding
Neurodegeneration
Surfaces, Coatings and Films
Physical and Theoretical Chemistry
Materials Chemistry
And 21 more
Most Relevant Publications (1+)

27 total publications

Effects of urea, metal ions and surfactants on the binding of baicalein with bovine serum albumin

Journal of Pharmaceutical Analysis / Aug 01, 2016

Roy, A. S., Dinda, A. K., Pandey, N. K., & Dasgupta, S. (2016). Effects of urea, metal ions and surfactants on the binding of baicalein with bovine serum albumin. Journal of Pharmaceutical Analysis, 6(4), 256–267. https://doi.org/10.1016/j.jpha.2016.04.001

See Full Profile

Vicky Mody

Associate Professor
Most Relevant Research Expertise
Pharmacy
Other Research Expertise (13)
Bioengineering
Physical and Theoretical Chemistry
Atomic and Molecular Physics, and Optics
Cell Biology
Biotechnology
And 8 more
Most Relevant Publications (2+)

36 total publications

Effectiveness of flipped classroom instructional model in teaching pharmaceutical calculations

Currents in Pharmacy Teaching and Learning / Sep 01, 2016

Cotta, K. I., Shah, S., Almgren, M. M., Macías-Moriarity, L. Z., & Mody, V. (2016). Effectiveness of flipped classroom instructional model in teaching pharmaceutical calculations. Currents in Pharmacy Teaching and Learning, 8(5), 646–653. https://doi.org/10.1016/j.cptl.2016.06.011

Evaluation of criteria utilized in the recognition of teaching excellence awards

Currents in Pharmacy Teaching and Learning / Jul 01, 2016

Kiersma, M. E., Chen, A. M. H., Kleppinger, E. L., Blake, E. W., Fusco, N. M., Mody, V., Gillespie, M. E., Knell, M., & Zavod, R. M. (2016). Evaluation of criteria utilized in the recognition of teaching excellence awards. Currents in Pharmacy Teaching and Learning, 8(4), 477–484. https://doi.org/10.1016/j.cptl.2016.03.003

See Full Profile

Parisa Lotfi

Education

University of Texas at Arlington

UT Southwestern Medical Center

Research Expertise (0)

See Full Profile

Michael Avaltroni

Education

Princeton University

Research Expertise (0)

See Full Profile

Example Pharmacy projects

How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on Pharmacy?

Development of Novel Drug Delivery Systems

An academic researcher in Pharmacy can collaborate with a pharmaceutical company to develop innovative drug delivery systems. This can include the design of nanoparticles, liposomes, or implants that improve drug efficacy and patient compliance.

Pharmacogenomics Research

Companies can benefit from collaborating with a Pharmacy researcher in pharmacogenomics. This field focuses on understanding how an individual's genetic makeup influences their response to drugs. By incorporating pharmacogenomic data into drug development, companies can create personalized treatment options.

Drug Repurposing Studies

Academic researchers can collaborate with companies to explore the potential of repurposing existing drugs for new indications. This can lead to cost-effective solutions and faster development timelines, as the safety profiles of these drugs are already established.

Pharmacy Automation and Robotics

Collaborating with a Pharmacy researcher specializing in automation and robotics can help companies streamline their operations. This includes the development of automated dispensing systems, robotic medication compounding, and inventory management solutions.

Pharmaceutical Policy and Health Economics

Companies can benefit from the expertise of Pharmacy researchers in pharmaceutical policy and health economics. These researchers can provide insights into pricing strategies, market access, and cost-effectiveness analyses, helping companies optimize their business strategies.